Review



mnng hos os cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC mnng hos os cells
    Mnng Hos Os Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1075 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pmc12335688-35-28-35?v=ATCC
    Average 96 stars, based on 1075 article reviews
    mnng hos os cells - by Bioz Stars, 2026-07
    96/100 stars

    Images



    Similar Products

    96
    ATCC mnng hos os cells
    Mnng Hos Os Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pmc12335688-35-28-35?v=ATCC
    Average 96 stars, based on 1 article reviews
    mnng hos os cells - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    DS Pharma Biomedical human os cell line mnng/hos
    Human Os Cell Line Mnng/Hos, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/10__1016_slash_j__omton__2024__200845-130-1-9?v=DS+Pharma+Biomedical
    Average 90 stars, based on 1 article reviews
    human os cell line mnng/hos - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    ATCC human os cell line mnng hos mnng
    Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in <t>MNNG</t> cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001
    Human Os Cell Line Mnng Hos Mnng, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pmc11193292-37-1-18?v=ATCC
    Average 96 stars, based on 1 article reviews
    human os cell line mnng hos mnng - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    ATCC human osteosarcoma os cell lines mnng hos
    Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in <t>MNNG</t> cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001
    Human Osteosarcoma Os Cell Lines Mnng Hos, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pm38847478-31-1-13?v=ATCC
    Average 96 stars, based on 1 article reviews
    human osteosarcoma os cell lines mnng hos - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    Procell Inc human osteosarcoma cell lines (mnng/hos, mg-63, 143b, and u-2 os)
    Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in <t>MNNG</t> cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001
    Human Osteosarcoma Cell Lines (Mnng/Hos, Mg 63, 143b, And U 2 Os), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pm36871636-53-12-25?v=Procell+Inc
    Average 90 stars, based on 1 article reviews
    human osteosarcoma cell lines (mnng/hos, mg-63, 143b, and u-2 os) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    ATCC human os cell lines mnng hos
    Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in <t>MNNG</t> cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001
    Human Os Cell Lines Mnng Hos, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pm34857735-45-1-25?v=ATCC
    Average 96 stars, based on 1 article reviews
    human os cell lines mnng hos - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    ATCC human os cell line hos mnng
    Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in <t>MNNG</t> cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001
    Human Os Cell Line Hos Mnng, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mnng+hos+os+cells/pmc08709858-54-12-20?v=ATCC
    Average 96 stars, based on 1 article reviews
    human os cell line hos mnng - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in MNNG cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001

    Journal: Journal of Nanobiotechnology

    Article Title: Cargo-eliminated osteosarcoma-derived small extracellular vesicles mediating competitive cellular uptake for inhibiting pulmonary metastasis of osteosarcoma

    doi: 10.1186/s12951-024-02636-9

    Figure Lengend Snippet: Characterization of OS-sEVs and CE-sEVs. (A) Western blot analysis of sEVs characteristic markers (CD9, CD63, and TSG101) and non-sEVs marker GM130 in MNNG cells and OS-sEV. (B) Representative TEM images of OS-sEVs and CE-sEVs. Scale bar: 100 nm. (C) Particle size distribution of OS-sEVs and CE-sEVs. (D) Quantification of the mean protein concentration per particle of OS-sEVs and CE-sEVs ( n = 3). (E) Sliver staining image of total proteins in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) and (F) the quantification of the relative protein content of OS-sEVs and CE-sEVs ( n = 3). (G) RNA enrichment analysis depicted in FU per nt of total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles). (H) Total RNA contents in OS-sEVs (1 × 10 10 particles) and CE-sEVs (1 × 10 10 particles) by SYTO™ RNA staining ( n = 3). *** P < 0.001; # P < 0.0001

    Article Snippet: The human OS cell line MNNG/HOS (MNNG) and the human osteoblast cell line hFOB1.19 were purchased from the American Type Culture Collection (ATCC).

    Techniques: Western Blot, Marker, Protein Concentration, Staining

    CE-sEVs exhibit no tumor-promoting ability. (A) CCK-8 assay detects the proliferation of MNNG cells after treated with OS-sEVs and CE-sEVs, the results confirm that OS-sEVs promoted OS cell proliferation, while CE-sEVs did not have such effect ( n = 3). (B) Transwell assay detects the migration of MNNG cells after treated with OS-sEVs and CE-sEVs, the results confirm that OS-sEVs promoted OS cell migration, while CE-sEVs did not have such effect ( n = 3). (C) Tumor resection images after intravenous intervention with OS-sEVs ( n = 5), CE-sEVs ( n = 5), and control ( n = 5) in the nude mouse subcutaneous tumor model, administered three times per week. (D) Quantitation of tumor weight (mean ± SD). (E) Quantitation of tumor volume (mean ± SD). ns P > 0.05; * P < 0.05; *** P < 0.001

    Journal: Journal of Nanobiotechnology

    Article Title: Cargo-eliminated osteosarcoma-derived small extracellular vesicles mediating competitive cellular uptake for inhibiting pulmonary metastasis of osteosarcoma

    doi: 10.1186/s12951-024-02636-9

    Figure Lengend Snippet: CE-sEVs exhibit no tumor-promoting ability. (A) CCK-8 assay detects the proliferation of MNNG cells after treated with OS-sEVs and CE-sEVs, the results confirm that OS-sEVs promoted OS cell proliferation, while CE-sEVs did not have such effect ( n = 3). (B) Transwell assay detects the migration of MNNG cells after treated with OS-sEVs and CE-sEVs, the results confirm that OS-sEVs promoted OS cell migration, while CE-sEVs did not have such effect ( n = 3). (C) Tumor resection images after intravenous intervention with OS-sEVs ( n = 5), CE-sEVs ( n = 5), and control ( n = 5) in the nude mouse subcutaneous tumor model, administered three times per week. (D) Quantitation of tumor weight (mean ± SD). (E) Quantitation of tumor volume (mean ± SD). ns P > 0.05; * P < 0.05; *** P < 0.001

    Article Snippet: The human OS cell line MNNG/HOS (MNNG) and the human osteoblast cell line hFOB1.19 were purchased from the American Type Culture Collection (ATCC).

    Techniques: CCK-8 Assay, Transwell Assay, Migration, Control, Quantitation Assay

    CE-sEVs efficiently suppressed the pulmonary metastasis of OS. (A) Schematic representation of the experimental metastasis model of OS. The mice were divided into three groups and pretreated with blank (control group), OS-sEVs (OS-sEVs group), OS-sEVs + CE-sEVs (CE-sEVs group) every three days. Then, MNNG cells were intravenous injection on day 12, mice were euthanized on day 28, and lungs were excised for observation of metastasis using BLI. (B) Representative ex vivo BLI of the lungs in experimental metastasis model, and the pulmonary metastasis of MNNG cells were calculated based on the lung’s FI value. (C) Quantification of lung’s FI in experimental metastasis model ( n = 4/5). (D) Schematic representation of the spontaneous metastasis model of OS. The mice received MNNG cells inoculation into the tibia on day 0, and then divided into three groups: the control group (administered with blank), the PBS group (administered with PBS), and the CE-sEVs group (administered with CE-sEVs). Thrice-weekly interventions were performed. At the end of week 4, the mice were euthanized, and lungs were excised for observation of metastasis using BLI. (E) Representative ex vivo BLI of the primary tumors and lungs in spontaneous metastasis model, and the pulmonary metastasis of MNNG cells were calculated based on the lung’s FI value. (F) Quantification of lung’s FI in spontaneous metastasis model by BLI ( n = 4/5). (G) Kaplan-Meier analysis of survival time in mice with spontaneous OS metastasis model ( n = 8). ns P > 0.05; * P < 0.05; ** P < 0.01

    Journal: Journal of Nanobiotechnology

    Article Title: Cargo-eliminated osteosarcoma-derived small extracellular vesicles mediating competitive cellular uptake for inhibiting pulmonary metastasis of osteosarcoma

    doi: 10.1186/s12951-024-02636-9

    Figure Lengend Snippet: CE-sEVs efficiently suppressed the pulmonary metastasis of OS. (A) Schematic representation of the experimental metastasis model of OS. The mice were divided into three groups and pretreated with blank (control group), OS-sEVs (OS-sEVs group), OS-sEVs + CE-sEVs (CE-sEVs group) every three days. Then, MNNG cells were intravenous injection on day 12, mice were euthanized on day 28, and lungs were excised for observation of metastasis using BLI. (B) Representative ex vivo BLI of the lungs in experimental metastasis model, and the pulmonary metastasis of MNNG cells were calculated based on the lung’s FI value. (C) Quantification of lung’s FI in experimental metastasis model ( n = 4/5). (D) Schematic representation of the spontaneous metastasis model of OS. The mice received MNNG cells inoculation into the tibia on day 0, and then divided into three groups: the control group (administered with blank), the PBS group (administered with PBS), and the CE-sEVs group (administered with CE-sEVs). Thrice-weekly interventions were performed. At the end of week 4, the mice were euthanized, and lungs were excised for observation of metastasis using BLI. (E) Representative ex vivo BLI of the primary tumors and lungs in spontaneous metastasis model, and the pulmonary metastasis of MNNG cells were calculated based on the lung’s FI value. (F) Quantification of lung’s FI in spontaneous metastasis model by BLI ( n = 4/5). (G) Kaplan-Meier analysis of survival time in mice with spontaneous OS metastasis model ( n = 8). ns P > 0.05; * P < 0.05; ** P < 0.01

    Article Snippet: The human OS cell line MNNG/HOS (MNNG) and the human osteoblast cell line hFOB1.19 were purchased from the American Type Culture Collection (ATCC).

    Techniques: Control, Injection, Ex Vivo